SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma’s arm acquires remaining 10% stake in Upakarma

03 Jun 2026 Evaluate

Mankind Pharma’s wholly owned subsidiary (WOS) -- Mankind Lifesciences (MLS) has acquired the remaining 10% stake of Upakarma Ayurveda (Upakarma) from Kaushcorp Media LLP through a share purchase agreement (SPA) for Rs 75 lakh (payable in two tranches as per SPA) on June 2, 2026. MLS is already holding 90% stake in Upakarma.

This acquisition will enable the company to achieve better operational efficiencies through streamlined processes. Consequent to this acquisition, Upakarma has become a WOS of MLS and a step-down WOS of the company.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Mankind Pharma Share Price

2531.15 43.75 (1.76%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: